These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32248400)

  • 1. Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects.
    Lie MEK; Kickinger S; Skovgaard-Petersen J; Ecker GF; Clausen RP; Schousboe A; White HS; Wellendorph P
    Neurochem Res; 2020 Jul; 45(7):1551-1565. PubMed ID: 32248400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice.
    Lehre AC; Rowley NM; Zhou Y; Holmseth S; Guo C; Holen T; Hua R; Laake P; Olofsson AM; Poblete-Naredo I; Rusakov DA; Madsen KK; Clausen RP; Schousboe A; White HS; Danbolt NC
    Epilepsy Res; 2011 Jun; 95(1-2):70-81. PubMed ID: 21459558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.
    Madsen KK; Ebert B; Clausen RP; Krogsgaard-Larsen P; Schousboe A; White HS
    J Pharmacol Exp Ther; 2011 Jul; 338(1):214-9. PubMed ID: 21450931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
    White HS; Watson WP; Hansen SL; Slough S; Perregaard J; Sarup A; Bolvig T; Petersen G; Larsson OM; Clausen RP; Frølund B; Falch E; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2005 Feb; 312(2):866-74. PubMed ID: 15550575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and molecular aspects of betaine-GABA transporter 1 (BGT1) and its relation to brain function.
    Kickinger S; Hellsberg E; Frølund B; Schousboe A; Ecker GF; Wellendorph P
    Neuropharmacology; 2019 Dec; 161():107644. PubMed ID: 31108110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological identification of a guanidine-containing β-alanine analogue with low micromolar potency and selectivity for the betaine/GABA transporter 1 (BGT1).
    Al-Khawaja A; Petersen JG; Damgaard M; Jensen MH; Vogensen SB; Lie ME; Kragholm B; Bräuner-Osborne H; Clausen RP; Frølund B; Wellendorph P
    Neurochem Res; 2014 Oct; 39(10):1988-96. PubMed ID: 24852577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Characterization of [
    Al-Khawaja A; Haugaard AS; Marek A; Löffler R; Thiesen L; Santiveri M; Damgaard M; Bundgaard C; Frølund B; Wellendorph P
    ACS Chem Neurosci; 2018 Mar; 9(3):545-554. PubMed ID: 29131576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs.
    Madsen KK; Clausen RP; Larsson OM; Krogsgaard-Larsen P; Schousboe A; White HS
    J Neurochem; 2009 May; 109 Suppl 1():139-44. PubMed ID: 19393020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs.
    Madsen KK; White HS; Schousboe A
    Pharmacol Ther; 2010 Mar; 125(3):394-401. PubMed ID: 20026354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Determinants and Pharmacological Analysis for a Class of Competitive Non-transported Bicyclic Inhibitors of the Betaine/GABA Transporter BGT1.
    Kickinger S; Lie MEK; Suemasa A; Al-Khawaja A; Fujiwara K; Watanabe M; Wilhelmsen KS; Falk-Petersen CB; Frølund B; Shuto S; Ecker GF; Wellendorph P
    Front Chem; 2021; 9():736457. PubMed ID: 34595152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile.
    Kragholm B; Kvist T; Madsen KK; Jørgensen L; Vogensen SB; Schousboe A; Clausen RP; Jensen AA; Bräuner-Osborne H
    Biochem Pharmacol; 2013 Aug; 86(4):521-8. PubMed ID: 23792119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti-seizure medication.
    Fukushima K; Higashiyama H; Kazuta Y; Hashimoto K; Watanabe N; Furuya Y; Ito Y; Wu T; Kosasa T; Talos DM; Song Y; Roberts NS; Jensen FE; Hanada T; Ido K
    Epilepsia Open; 2023 Sep; 8(3):834-845. PubMed ID: 37052238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures.
    Gerile ; Sogawa C; Ohyama K; Masuko T; Kusama T; Morita K; Sogawa N; Kitayama S
    Int J Mol Sci; 2012; 13(3):2578-2589. PubMed ID: 22489112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcellular localization of GABA transporters and its implication for seizure management.
    Madsen KK; Hansen GH; Danielsen EM; Schousboe A
    Neurochem Res; 2015 Feb; 40(2):410-9. PubMed ID: 25519681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA transport inhibitors and seizure protection: the past and future.
    Schousboe A; Madsen KK; White HS
    Future Med Chem; 2011 Feb; 3(2):183-7. PubMed ID: 21428813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Search for Betaine/GABA Transporter 1 Inhibitors─
    Łątka K; Kickinger S; Rzepka Z; Zaręba P; Latacz G; Siwek A; Wolak M; Stary D; Marcinkowska M; Wellendorph P; Wrześniok D; Bajda M
    ACS Chem Neurosci; 2024 Nov; 15(21):4046-4054. PubMed ID: 39425769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the molecular determinants for subtype-selectivity of 2-amino-1,4,5,6-tetrahydropyrimidine-5-carboxylic acid analogs as betaine/GABA transporter 1 (BGT1) substrate-inhibitors.
    Kickinger S; Al-Khawaja A; Haugaard AS; Lie MEK; Bavo F; Löffler R; Damgaard M; Ecker GF; Frølund B; Wellendorph P
    Sci Rep; 2020 Aug; 10(1):12992. PubMed ID: 32747622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Non-GAT1-Selective Inhibitors: Challenges and Achievements.
    Damgaard M; Haugaard AS; Kickinger S; Al-Khawaja A; Lie MEK; Ecker GF; Clausen RP; Frølund B
    Adv Neurobiol; 2017; 16():315-332. PubMed ID: 28828618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain.
    Tachikawa M; Yashiki A; Akanuma SI; Matsukawa H; Ide S; Minami M; Hosoya KI
    Neurochem Int; 2018 Feb; 113():1-7. PubMed ID: 29175673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.